Topochemical catalysis achieved by structure-based ligand design

被引:8
|
作者
Katz, BA
Cass, RT
Liu, BS
Arze, R
Collins, N
机构
[1] Arris Pharmaceutical Corporation, South San Francisco
关键词
D O I
10.1074/jbc.270.52.31210
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, a cyclic peptide ligand, cyclo-Ac-[CHPQG-PPC]-NH2, that binds to streptavidin with high affinity was discovered by screening phage libraries, From the streptavidin-bound crystal structures of cyclo-Ac[CHPQGPPC]-NH2 and of a related but more weakly binding linear ligand, FSHPQNT, we designed linear thiol-containing streptavidin binding ligands, FCH-PQNT-NH2, and Ac-CHPQNT-NH2, which are dimerized catalytically by the streptavidin crystal lattice of space group I222, as demonstrated by high performance liquid chromatography and mass spectrometry, The catalytic dimerization relies on presentation of the ligand thiols toward one another in the lattice, The streptavidin crystal lattice mediated catalysis achieved by structure-based design is the first example of catalysis of a chemical reaction by a protein crystal lattice, The spontaneous and crystal catalyzed rates of disulfide formation were determined by high performance liquid chromatography at pH 3.1, 4.0, 5.0, and 6.0. The ratio of the catalyzed to uncatalyzed rate was maximal at pH 3.1 (k(cat)/k(uncat) = 3.8), diminishing to 1.2 at pH 6.0. The crystal structures of the streptavidin bound dimerized peptide ligands, FCHPQNT-NH2 dimer at 1.95 Angstrom and Ac-CHPQNT-NH22 dimer at 1.80 Angstrom, are described and compared with the structures of streptavidin-bound FSHPQNT monomer and cyclo-Ac-[CHPQGPPC]-NH2 dimer.
引用
收藏
页码:31210 / 31218
页数:9
相关论文
共 50 条
  • [21] Combining ligand- and structure-based methods in drug design projects
    Sperandio, Olivier
    Miteva, Maria A.
    Villoutreix, Bruno O.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2008, 4 (03) : 250 - 258
  • [22] The role of structure-based ligand design and molecular modelling in drug discovery
    Tollenaere, JP
    PHARMACY WORLD & SCIENCE, 1996, 18 (02): : 56 - 62
  • [23] Preparation of a protein-dimerizing ligand by topochemistry and structure-based design
    Katz, BA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (10) : 2535 - 2536
  • [24] Structure-Based Ligand Design of Novel Bacterial RNA Polymerase Inhibitors
    McPhillie, Martin J.
    Trowbridge, Rachel
    Mariner, Katherine R.
    O'Neill, Alex J.
    Johnson, A. Peter
    Chopra, Ian
    Fishwick, Colin W. G.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (10): : 729 - 734
  • [25] Structure-Based Design of a Monosaccharide Ligand Targeting Galectin-8
    Bohari, Mohammad H.
    Yu, Xing
    Kishor, Chandan
    Patel, Brijesh
    Go, Rob Marc
    Seyedi, Hadieh A. Eslampanah
    Vinik, Yaron
    Grice, I. Darren
    Zick, Yehiel
    Blanchard, Helen
    CHEMMEDCHEM, 2018, 13 (16) : 1664 - 1672
  • [26] Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug Discovery
    Hunter, William N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (18) : 11749 - 11753
  • [27] Water-centric methods in structure-based GPCR ligand design
    Bortolato, Andrea
    Mason, Jonathan
    Deflorian, Francesca
    Tehan, Benjamin
    Smith, Rob
    Cooke, Rob
    Zhukov, Andrei
    Marshall, Fiona
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [28] Ligand- and Structure-Based Drug Design and Optimization using KNIME
    Mazanetz, Michael P.
    Goode, Charlotte H. F.
    Chudyk, Ewa, I
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (38) : 6458 - 6479
  • [29] Role for chemoinformatics in structure-based de novo ligand design.
    Johnson, AP
    Boda, K
    Lengyel, T
    Weaver, S
    Vigh, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U363 - U363
  • [30] Ligand- and Structure-Based Drug Design Strategies and PPARδ/α Selectivity
    Maltarollo, Vinicius G.
    Honorio, Kathia M.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (04) : 533 - 544